With a sustained recruitment policy of 10% annual hiring, Horus Pharma has established itself as a thriving SME and employment generator in the Nice area.

Innovation takes the form of a sustained rate of product launches, patent filing and expansion of the product portfolio, which includes more than 50 specialities today, to progressively cover all therapeutic segments in ophthalmology.

With an international focus since 2010, Horus Pharma has a voluntary Export policy, through the constant expansion of its distribution network, covering 12 countries in Western Europe, North America and Asia including Russia. This dynamic of extension is coupled with the launch of the first European subsidiaries in 2015.